Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. （打开新窗口）

Barillari G, Pasca S, Barillari A, De Angelis V.

来源‎: Blood Transfus 2012;10(1):87-94.

检索‎: PubMed 22044952

DOI码‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 （打开新窗口）

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. （打开新窗口）

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

来源‎: Chest 2012;141(2 Suppl):e326S-50S.

检索‎: PubMed 22315266

DOI码‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 （打开新窗口）

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. （打开新窗口）

Flordal PA.

来源‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

检索‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 （打开新窗口）

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. （打开新窗口）

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

来源‎: Lancet 2015;385(9982):2077-87.

检索‎: PubMed 25728933

DOI码‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 （打开新窗口）

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. （打开新窗口）

Goodnough LT, Shander A.

来源‎: Blood 2011;117(23):6091-9.

检索‎: PubMed 21411756

DOI码‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 （打开新窗口）

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. （打开新窗口）

Hanke AA, Joch C, Görlinger K.

来源‎: Br J Anaesth 2013;110(5):764-72.

检索‎: PubMed 23335567

DOI码‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 （打开新窗口）

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. （打开新窗口）

Jaben EA, Mulay SB, Stubbs JR.

来源‎: J Intensive Care Med 2015;30(1):3-7.

检索‎: PubMed 25492811

DOI码‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 （打开新窗口）

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. （打开新窗口）

Levi M, Eerenberg E, Kamphuisen PW.

来源‎: J Thromb Haemost 2011;9(9):1705-12.

检索‎: PubMed 21729240

DOI码‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 （打开新窗口）

Emergency reversal of warfarin anticoagulation. （打开新窗口）

Lin Y, Callum J.

来源‎: CMAJ 2010;182(18):2004.

检索‎: PubMed 21078740

DOI码‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 （打开新窗口）

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. （打开新窗口）

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

来源‎: Thromb Haemost 2012;108(2):217-24.

检索‎: PubMed 22627883

DOI码‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 （打开新窗口）

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. （打开新窗口）

Mo Y, Yam FK.

来源‎: Pharmacotherapy 2015;35(2):198-207.

检索‎: PubMed 25644580

DOI码‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 （打开新窗口）

Idarucizumab for dabigatran reversal - full cohort analysis. （打开新窗口）

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

来源‎: N Engl J Med 2017;377(5):431-41.

检索‎: PubMed 28693366

DOI码‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 （打开新窗口）

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. （打开新窗口）

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

来源‎: Anesth Analg 2011;113(4):703-10.

检索‎: PubMed 21890888

DOI码‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 （打开新窗口）

Oral anticoagulation in surgical procedures: risks and recommendations. （打开新窗口）

Torn M, Rosendaal FR.

来源‎: Br J Haematol 2003;123(4):676-82.

检索‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 （打开新窗口）

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. （打开新窗口）

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

来源‎: Blood 2012;119(9):2172-4.

检索‎: PubMed 22383791

DOI码‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 （打开新窗口）